Human stem cell-based embryo model governance: Insights from Japan.
Where this comes from
- Record sourced from PubMed, PMID 42392051.
- Also identified by DOI 10.1016/j.stem.2026.05.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite rapid advances in human stem cell-based embryo model (SCBEM) research, national regulatory frameworks remain limited. On April 1, 2026, Japan implemented revised guidelines extending their scope to encompass human SCBEM research. We examine the revisions, differences from ISSCR guidelines, and practical challenges arising during the international regulatory transition period.
Medical subject headings
- Embryo Research
- Models, Biological
- Human Embryonic Stem Cells